Detalles de la búsqueda
1.
The Novel SSTR3 Agonist ITF2984 Exerts Antimitotic and Proapoptotic Effects in Human Non-Functioning Pituitary Neuroendocrine Tumor (NF-PitNET) Cells.
Int J Mol Sci
; 25(7)2024 Mar 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-38612419
2.
Altered splicing machinery in lung carcinoids unveils NOVA1, PRPF8 and SRSF10 as novel candidates to understand tumor biology and expand biomarker discovery.
J Transl Med
; 21(1): 879, 2023 12 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38049848
3.
Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior.
Neuroendocrinology
; 112(1): 15-33, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-33524974
4.
Beta-Arrestin 2 Is Required for Dopamine Receptor Type 2 Inhibitory Effects on AKT Phosphorylation and Cell Proliferation in Pituitary Tumors.
Neuroendocrinology
; 111(6): 568-579, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-32512568
5.
Cytoskeleton Protein Filamin A Is Required for Efficient Somatostatin Receptor Type 2 Internalization and Recycling through Rab5 and Rab4 Sorting Endosomes in Tumor Somatotroph Cells.
Neuroendocrinology
; 110(7-8): 642-652, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31574507
6.
A ß-Arrestin 2-Biased Dopamine Receptor Type 2 (DRD2) Agonist Is More Efficacious Than Cabergoline in Reducing Cell Proliferation in PRL-Secreting but Not in Non-Functioning Pituitary Tumor Cells.
Cancers (Basel)
; 15(12)2023 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37370829
7.
Role of filamin A in the pathogenesis of neuroendocrine tumors and adrenal cancer.
Endocr Oncol
; 2(1): R143-R152, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37435454
8.
TMPRSS2 Expression and Activity Modulation by Sex-Related Hormones in Lung Calu-3 Cells: Impact on Gender-Specific SARS-CoV-2 Infection.
Front Endocrinol (Lausanne)
; 13: 862789, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35712238
9.
Dimerization of GPCRs: Novel insight into the role of FLNA and SSAs regulating SST2 and SST5 homo- and hetero-dimer formation.
Front Endocrinol (Lausanne)
; 13: 892668, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35992099
10.
DRD2 Agonist Cabergoline Abolished the Escape Mechanism Induced by mTOR Inhibitor Everolimus in Tumoral Pituitary Cells.
Front Endocrinol (Lausanne)
; 13: 867822, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35721701
11.
P720R USP8 Mutation Is Associated with a Better Responsiveness to Pasireotide in ACTH-Secreting PitNETs.
Cancers (Basel)
; 14(10)2022 May 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-35626057
12.
Drug resistance in pituitary tumours: from cell membrane to intracellular signalling.
Nat Rev Endocrinol
; 17(9): 560-571, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34194011
13.
Filamin A is required for somatostatin receptor type 5 expression and pasireotide-mediated signaling in pituitary corticotroph tumor cells.
Mol Cell Endocrinol
; 524: 111159, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33428965
14.
USP8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs.
Endocr Relat Cancer
; 28(8): 573-582, 2021 06 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34086599
15.
Genetic Profiling of a Cohort of Italian Patients with ACTH-Secreting Pituitary Tumors and Characterization of a Novel USP8 Gene Variant.
Cancers (Basel)
; 13(16)2021 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34439178
16.
A Novel Mechanism Regulating Dopamine Receptor Type 2 Signal Transduction in Pituitary Tumoral Cells: The Role of cAMP/PKA-Induced Filamin A Phosphorylation.
Front Endocrinol (Lausanne)
; 11: 611752, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33664708
17.
Stem Cells in Pituitary Tumors: Experimental Evidence Supporting Their Existence and Their Role in Tumor Clinical Behavior.
Front Endocrinol (Lausanne)
; 10: 745, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31708878
18.
Somatostatin analogs regulate tumor corticotrophs growth by reducing ERK1/2 activity.
Mol Cell Endocrinol
; 483: 31-38, 2019 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30611770
Resultados
1 -
18
de 18
1
Próxima >
>>